Objectives: This study aimed to develop and validate three simple, accurate, selective, reproducible and sensitive spectrophotometric methods for the determination of oxfendazole in the presence of its alkali-induced degradation product without preliminary separation. Methods: (A) first derivative spectrophotometry ( 1 D) method at 298.9 nm, (B) first derivative of ratio spectra ( 1 DD) method at 295.4 nm and (C) area under the curve (AUC) method at wavelength ranges of (290-294 nm) and (297-301 nm). All methods were applied in the range of (1-10µg mL -1 ). Results: These methods were validated and successfully applied for determination of oxfendazole in Unifendazole® suspension. The obtained results were statistically compared with those of the reported method by applying t-test and F-test at 95% confidence level and no significant difference was observed regarding accuracy and precision. Conclusion: The proposed methods are simple, rapid, economic, accurate and precise to determine oxfendazole in the presence of its alkali-induced degradation product without previous separation steps.
INTRODUCTION
Oxfendazole is chemically known as: [5- (Phenylsulfinyl)-1H-benzimidazol-2-yl] carbamic acid methyl ester 1 ( Figure 1 ). It is a benzimidazole carbamate anthelmintic used in veterinary medicine, for protecting livestock against roundworm, strongyles, and pinworms. 2 
Figure 1. Chemical structure of oxfendazole
Different analytical techniques were applied for quantitative estimation of oxfendazole including potentiometric titration 3, 4 , radio immunoassay 5 , colorimetric (based on the measurement of green colored manganate obtained due to oxidation of oxfendazole by permanganate in an alkaline medium at 610 nm) and direct measurement (at 290 nm in the acetic acid-water (1:1) solvent system) spectrophotometric methods 6 and HPLC methods either alone or in presence of other compounds [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] .
Oxfendazole is an amide group containing compound that made it highly sensitive to hydrolytic degradation in basic conditions with the production of the degradation product (2-amino-5-Phenylsulfinyl benzimidazole).
There is no stability indicating analytical methods were reported for determination of oxfendazole in presence of its degradation product.
The aim of this work is to develop and validate simple, sensitive and selective spectrophotometric methods for the determination of oxfendazole in presence of its alkali-induced degradation product (2-amino-5-phenylsulfinyl benzimidazole) without preliminary separation.
MATERIALS AND METHODS

Instruments
Shimadzu UV-Vis. 1650 Spectrophotometer, (Japan), equipped with 10 mm matched quartz cells. Hot plate (Torrey pines Scientific, USA). Jenway, 3510 pH meter (Jenway, USA). Rotatory evaporator (Scilogex-RE 100-pro, USA). Pye-Unicam SP-3-300 infrared spectro-photometer (potassium bromide dicks). GCMS-QP-1000EX mass spectrometer at 70 ev (Shimadzu, Tokyo, Japan).
Materials and Reagents
Pure standard
Standard oxfendazole powder was kindly supplied by Unipharma Co. for pharmaceutical industries, Al Obour city, Cairo, Egypt. (B. NO: 60414005).
Pharmaceutical preparation
Unifendazole ® suspension, the product of Unipharma Co. for pharmaceutical industries, Al Obour city, Cairo, Egypt. (B.NO: 390215), which labeled to contain 22.5% w/v oxfendazole.
Reagents and solvents
Hydrochloric acid, (El-Nasr Co., Egypt), prepared as 0.1M methanolic solution and 1M aqueous solution. Sodium hydroxide, (El-Nasr Co., Egypt), prepared as 1M aqueous solution. Methanol.
Degraded sample
One gram of oxfendazole was dissolved in 25 mL 0.1M methanolic hydrochloric acid, and then transferred into 250 mL conical flask, then 50 mL of 1 M NaOH solution was added. The flask was heated to boiling under reflux for 1hr, cooled and neutralized with 1M HCl. Subsequently, the solution was dried under vacuum then the degradation product was extracted with methanol and re-crystallized after evaporating methanol.
Standard solutions
Stock standard solution of oxfendazole (1mg mL -1 ) was prepared by dissolving 0.1g of oxfendazole in 10 mL 0.1 M methanolic hydrochloric acid and complete to 100 mL with methanol. Working standard solution of oxfendazole (100 μg mL -1 ) was prepared by accurate transferring 10 mL of oxfendazole from its stock standard solution into 100 mL volumetric flask, then the volume was completed to the mark with methanol.
Stock standard solution of oxfendazole degradation product (1mg mL -1 ) was prepared by dissolving 0.1g of (2-amino-5-phenylsulfinyl benzimidazole) in 50 mL methanol and complete to 100 mL with the same solvent.
Working standard solution of oxfendazole degradation product (100 μg mL -1 ) was prepared by accurate transferring 10 mL of oxfendazole degradation product from its stock standard solution into 100 mL volumetric flask, then the volume was completed to the mark with methanol.
Methods
Construction of calibration curves
Different aliquots equivalent to (10 -100 µg) of both oxfendazole and its alkali-induced degradation product were accurately transferred from their standard solutions (100 µg mL -1 ) into two separate series of 10-mL volumetric flasks and completed to volume with methanol. The absorption spectra (from 200 to 400 nm) of these solutions were recorded using methanol as a blank.
First derivative method (
1 D) For the determination of oxfendazole in presence of its degradation product, the first derivative ( 1 D) of the zero-order spectra of oxfendazole and its degradation product were obtained. Then the amplitudes of the derivatized spectra of oxfendazole measured at 298.9nm, at which no interference from the degradation product, and plotted against corresponding drug concentrations, and the regression equation was derived.
First derivative of ratio spectra method ( 1 DD) For the determination of oxfendazole in presence of its degradation product, the zero-order spectra of oxfendazole were divided by the spectrum of 10 μg mL -1 of its degradation product to obtain ratio spectra, and then the first derivative of ratio spectra ( 1 DD) were obtained. Then the amplitudes of the derivatized ratio spectra measured at 295.4 nm were plotted against corresponding drug concentrations, and the regression equation was derived.
Area under the curve method (AUC)
The area under the curve (AUC) of oxfendazole and its degradation product were measured at both wavelength ranges of (290-294 nm) and (297-301nm) and calibration curves were obtained by plotting the area under curve values against the corresponding concentrations in μg mL -1 , and the regression equations were derived.
Application to laboratory prepared mixtures
Aliquots of oxfendazole and its degradation product were mixed to prepare different mixtures containing different ratios of both. The procedures mentioned under construction of calibration curves were followed and the concentrations of oxfendazole were calculated.
Application to pharmaceutical formulation
Volume of Unifendazole ® suspension (22.5w/v oxfendazole) equivalent to 250 mg oxfendazole was accurately taken and dissolved in 10 mL 0.1 M methanolic hydrochloric acid in 250 mL flask and volume was completed with methanol, shacked, and then filtered. 10 mL of the filtrate were accurately transferred into 100 mL volumetric flask and volume was completed with methanol to obtain a solution labeled to contain 100 µg mL -1 of oxfendazole. The solution was analyzed using the procedure described previously.
RESULTS AND DISCUSSION
Degradation of oxfendazole
It is found that complete alkaline degradation of oxfendazole was obtained after refluxing the drug with 1M sodium hydroxide at 100 °C for 1 hr, and the degradation was confirmed by TLC method using chloroform: methanol: acetic acid (90:8:2, by volume) as a developing system, where one spot of the degradation product obtained with significant separation from that of intact oxfendazole, where a suggested degradation pathway is shown as follows:
Scheme 1. Suggested degradation pathway of oxfendazole
Identification of the degradation product:
Infrared (IR) spectrum of the degradation product showed abroad peak at 3404 cm -1 which may be assigned to the primary amine group, also disappearance of the peaks at 2741 cm -1 of the methyl group and at 1724 cm In conclusion, all the above evidences indicate that the degradation product could be 2-amino-5-Phenylsulfinyl benzimidazole (Scheme 1). 
Spectral characteristics
The zero-order absorption spectra of oxfendazole and its alkali-induced degradation product show severe overlap, as shown in Figure 5 . This overlap does not permit direct determination of oxfendazole in the presence of its degradation product. To overcome this problem, different spectrophotometric methods were developed and validated to allow the determination of oxfendazole in the presence of its alkali-induced degradation product without previous separation. 18, 19 Derivative spectrophotometry offers a powerful tool for a better resolution enhancement when signal overlap or interference exists. The first derivatives of the absorption spectra were obtained to allow quantitative determination of oxfendazole in the presence of its degradation product, where the amplitudes at 298.9 nm are proportional to the concentrations of oxfendazole without interference from its degradation product, as shown in Figures 6, 7 . First derivative of ratio spectra 20, 21 First derivative of ratio spectra method is a simple method, capable of determining oxfendazole in presence of its alkali-induced degradation product with minimal data processing. In this method, the absorption spectra of the drug were divided by the absorption spectrum of the degradation product (10 μg mL -1 ), as a divisor, to get the ratio spectra, as shown in Figure 8 . The amplitudes of the first derivative of the ratio spectra at 295.4 nm are proportional to the concentrations of the drug without interference from its degradation product (divisor), as shown in Area under the curve method 22, 23 In this method, the area under the curve for oxfendazole and its degradation product were recorded over wavelength ranges of (290-294 nm) and (297-301 nm), Figures 11, 12 . The absorptivity 'a' values of oxfendazole and its degradation product were determined at each wavelength range. The concentrations of oxfendazole in presence of its degradation product can be obtained from the following equation:
First derivative method
C (x) = (Am1 ay2 -Am2 ay1) / (ax1 ay2 -ax2 ay1)
Where C(x) is oxfendazole concentration, Am1 and Am2 are the area under the curve of the mixture at the wavelength range (290 -294) nm and (297 -301) nm, respectively. Where ax1 = Ax1/conc. in µg mL -1 , ax2 = Ax2/conc. in µg mL-1 and ay1 = Ay1/conc. in µg mL -1 , ay2 = Ay2/conc. in µg mL -1 for oxfendazole and its degradation product, respectively. 
Methods of validation
Validations of the proposed methods were assessed as per the ICH guidelines (24) of accuracy, precision, repeatability, inter day precision, linearity.
Linearity and range
Calibration graphs were constructed by plotting the amplitudes of the first derivative and first derivative of ratio spectra methods or area under curve values for area under curve method at the selected wavelengths versus drug concentrations in μg mL -1 . The regression plot was found to be linear over the range of 1-10 µg mL Where y is the amplitude or area under curve values, x is the drug concentration in μg mL -1 and r 2 is the determination coefficient. Linearity range, regression equation, intercept, slope and determination coefficient for the calibration data were presented in Table 1 .
Limits of detection and quantitation
The limits of detection (LOD) and the limits of quantitation (LOQ) were calculated according to ICH guidelines from the following equations: LOD = 3.3 σ / S LOQ = 10 σ / S Where σ is the standard deviation of y-intercepts of regression lines and S is the slope of the calibration curve. LOD and LOQ values were mentioned in Table  1 .
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Accuracy
The proposed methods were applied for measuring different concentrations of oxfendazole within their linearity range and the concentrations were calculated each from their corresponding regression equations. The accuracy of the proposed methods was calculated and RSD% was obtained. Good results were obtained as shown in Table 1 .
Precision
Precision was evaluated by calculating intraday (repeatability) and interday (Intermediate precision) precision after repeating measuring of the three different concentrations three times in the same day and assaying the sample in triplicate on three successive days using the proposed methods. The calculated RSD% values were listed as shown in Table  1 indicating satisfying precision of the proposed methods.
Specificity
The specificity of the proposed methods was assured by applying them to laboratory prepared mixtures of the intact oxfendazole together with its degradation product. The proposed procedures were adopted for the selective determination of intact oxfendazole in presence of up to 80% of its degradation product for first derivative and first derivative of ratio spectra methods and up to 70% for area under curve method.
The mean percentage recovery ±SD % was shown in Table 2 . The validity of the proposed procedures is further assessed by applying the standard addition technique showing no interference from excipients. The results obtained were shown in Table 3 . Although area under the curve method was applied on zero-order absorption spectra and first derivative method needs only one data processing step, first derivative of ratio spectra method show the lowest LOD and LOQ values. All three methods are simple, time saving and easy in application.
Statistical analysis
In order to compare the ability of the proposed methods for the determination of oxfendazole in pharmaceutical preparation, the results obtained by applying each of the proposed methods and the reported spectrophotometric method 6 were subjected to statistical analysis Table 4 . The calculated t and F values were less than the theoretical ones indicating that there were no significant differences between the proposed and the reported methods. Another statistical comparison of the results obtained by the proposed methods and the reported method for determination of oxfendazole in pharmaceutical product using one-way ANOVA test was shown in 
CONCLUSION
In this research simple, rapid, accurate, reproducible, precise and sensitive methods namely, first derivative, first derivative of ratio spectra and area under the curve were described and applied for quantitative determination of oxfendazole in pure form or in the presence of its alkali-induced degradation product without any preliminary separation step. The proposed methods do not need any sophisticated apparatus or a special program and could be easily applied in quality control laboratories. Moreover, the proposed methods were successfully applied to Unifendazole ® suspension and no interference from pharmaceutical formulation excipients was found.
